New Biomarkers Identified for Predicting Prognosis in Laryngeal Cancer
Laryngeal cancer is a serious and aggressive cancer that occurs in the larynx, or voice box. Although it is not among the most common cancers, it carries a poor survival rate compared to many other cancers. Surgery remains a key treatment, but the risk of lymph node metastasis and recurrence is high. New biomarkers are urgently needed to improve early diagnosis, guide treatment, and predict patient outcomes more accurately. The Importance of m6A Modification and Ferroptosis Recent research has shown that RNA molecules can be chemically modified through a process called m6A methylation, which affects how genes are expressed and how cells behave. Another important process is ferroptosis, a form of cell death that depends on iron and oxidative stress. Both m6A modifications and ferroptosis are closely linked to cancer progression, including in laryngeal cancer. Understanding these connections opens up new possibilities for identifying key biomarkers and therapeutic targets. What This Stud...
